EAR
Get informed when a big investor buys or sells
+ Follow| Market cap | $53.36 Million |
|---|---|
| Enterprise Value | $25.58 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-39.68 |
| Beta | 1.48 |
| Outstanding Shares | 20,756,123 |
| P/E Ratio | -0.06 |
|---|---|
| PEG | 0.1 |
| Price to Sales | 2.57 |
| Price to Book Ratio | 1.29 |
| Enterprise Value to Revenue | 0.62 |
| Enterprise Value to EBIT | -0.28 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.71 |
| Debt to Equity | 0.4 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Eargo is a medical device company dedicated to improving the quality of life of people with hearing loss. The Company's innovative product and go-to-market approach address the major challenges of traditional hearing aid adoption, includ...